Cilia-free stem cells offer a new way to study rare diseases

Cilia-free stem cells offer a new way to study rare diseases ...

ciliopathies polycystic kidney disease are one of the most notable individuals who have developed tumours in cilia. These are the tiny hairlike structures on the surface of almost every cell type. The specific molecular-level problems in cilia that have triggered these diseases are inadequately understood.

In a novel experiment, scientists eliminated or deleted the cilia in a group of otherwise normal human pluripotent stem cells. Eventually, human tissues and mini-organ structures (organoids) derived from these cilia-free stem cells manifested ciliopathy-like symptoms.

The findings from the Journal of Natural Biomedical Engineering were published April 27.

We are attempting to understand what cilia do, so we ablated them from these cells, according to Benjamin Freedman, a lab at UW Medicine. We wanted to see if the cells would re-create symptoms of ciliopathy without the cilia. Sure enough, when we turned the cells into tissues and organoids (tissue-like structures), they re-created polycystic kidney disease and problems with brain development.

The cilia-knockout stem cells are a powerful new way to understand this type of diseases, which can be used to guide therapy development, according to Freedman, an associate professor of medicine at the University of Washington School of Medicine in Seattle.

cilia is described as cell compartments in which important proteins are combined as if in a Zoom meeting, to make cell development decisions. Without the meeting room, these proteins cannot talk to each other, and cell-development decisions are not made.

At least 15 ciliopathies are present at birth, each with its own collection of partially overlapping symptoms. Polycystic kidney disease (PKD) is a common condition, which affects one in 500 individuals and causes clinical difficulties most later in life.

Because ciliopathies affect many organs, pluripotent stem cells, which may transform into any tissue in the body, might offer a one-stop clinic to investigate these illnesses.

Freedman and his colleagues explored what would happen in their subsequent transformation into tissues and organoids. As it unfolded, the cilia-free stem cells appeared to be normal, but were unable to fully understand new forms.

Freedman said, at a certain point after they were turning into tissues, they seemed to break down. They struggled to transform into anything sophisticated. I believe the cilia will aid cells in their final phase of development.

The first time in 2000, the PKD might be stemmed from defects in the cilia, but scientists have discovered that the mechanism of damage that causes cysts to form has escaped. Together, researchers have a mechanism to test and compare molecular interactions in the cilia.

By comparing cells that lack cilia to those that have cilia but do not have PKD genes, we have a broad spectrum of cell types that may be used to deduce what''s happening among the molecules involved. For over 30 years, we''ve known the genes involved in PKDeven before we knew that cilia was implicated. Hopefully having these distinct cell types will assist us in understanding what specific limitations these genetic molecules can cause to create PKD.

You may also like: